Literature DB >> 33139898

Neoantigen vaccine proven safe and immunogenic.

Sarah Crunkhorn.   

Abstract

Year:  2020        PMID: 33139898     DOI: 10.1038/d41573-020-00194-x

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  1 in total

1.  A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder Cancer.

Authors:  Patrick A Ott; Siwen Hu-Lieskovan; Bartosz Chmielowski; Ramaswamy Govindan; Aung Naing; Nina Bhardwaj; Kim Margolin; Mark M Awad; Matthew D Hellmann; Jessica J Lin; Terence Friedlander; Meghan E Bushway; Kristen N Balogh; Tracey E Sciuto; Victoria Kohler; Samantha J Turnbull; Rana Besada; Riley R Curran; Benjamin Trapp; Julian Scherer; Asaf Poran; Dewi Harjanto; Dominik Barthelme; Ying Sonia Ting; Jesse Z Dong; Yvonne Ware; Yuting Huang; Zhengping Huang; Amy Wanamaker; Lisa D Cleary; Melissa A Moles; Kelledy Manson; Joel Greshock; Zakaria S Khondker; Ed Fritsch; Michael S Rooney; Mark DeMario; Richard B Gaynor; Lakshmi Srinivasan
Journal:  Cell       Date:  2020-10-15       Impact factor: 41.582

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.